Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer “Revision” indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor website/version update rather than any change to the study record content.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded Revision: v3.4.2 and removed the previous funding-status notice (v3.4.1) as part of the site update. These updates do not alter the trial information or how users access it.SummaryDifference0.4%

- Check82 days agoChange DetectedThe update introduces a site-wide funding notice and a new site version (v3.4.1), replacing the previous version (v3.4.0); these changes do not affect the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.